VGHCX quote
120.48up +0.63 +0.53%
Previous Close119.85CategoryHealth
Net Assets10.98 BilDividend Yield1.61%
Morningstar ratings:Minimum Initial Purchase25,000
RiskBelow Average1 Year Return33.67%
RatingRating: 4 out of 53 Year Return1.05%
ReturnAbove Average5 Year Return6.43%
Cumulative growth of a $10,000 investment
10k growth chart
20042005200620072008YTD
Growth9.51%26.38%40.12%46.33%19.34%35.15%
Value$10,951$12,638$14,012$14,633$11,934$13,515
Last NAV update 11/24/2009 8:00 PM ET   Financial data in U.S. dollars

Your latest quotes:  DISCA, VGHCX, STEC, VOD, ESLR, $COMPX

Overview
The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in equities of companies engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. The fund also considers companies engaged in medical, diagnostic, biochemical, and other research and development activities. It may invest up to 50% of its assets in foreign stocks.
More information for VGHCX
Fees and expenses
Front load0.00%
Deferred load0.00%
Expense Ratio0.29%
Top holdings for VGHCX
Company Name% Net Assets
Schering-Plough Corporation7.68%
Forest Laboratories, Inc.4.55%
McKesson, Inc.3.51%
AstraZeneca PLC3.43%
Abbott Laboratories3.38%
More top holdings for VGHCX
Additional Fund Information
Inception date05/23/1984
ManagerEdward P. Owens
Manager start date05/23/1984


Page generated 1:28 PM Eastern Time